Allogeneic cell therapy for a murine mammary carcinoma

Cancer Research

Volumn 58, Issue 17, 1998, Pages 3891-3895

  Morecki, Shoshana ^a   Yacovlev, Ellena ^a   Diab, Adi ^a   Slavin, Shimon ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; IMMUNOMODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

ADOPTIVE TRANSFER; ANIMALS; FEMALE; GRAFT VS HOST DISEASE; H-2 ANTIGENS; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; WHOLE-BODY IRRADIATION;

EID: 0032169968     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Herzig, R. H., Lynch, J., Christiansen, N. P., Fay, J. W., Davis, M. P., Stevens, D. A., Pineiro, L., and Herzig, G. P. Dose-intensive chemotherapy with etoposide-cyclophosphamide without stem cell support for advanced breast cancer: preliminary results. In: K. A. Dicke and A. Keating (eds.), Autologous Marrow and Blood Transplantation: Proceeding of the Seventh International Symposium, pp. 211-214. Arlington, Texas: The Cancer Treatment Research and Educational Institute, 1994.
2. Reiffers, J., Stoppa, A. M., Attal, M., Michallet, M., Fegueux, N., Marit, G., Biaise, D., Huguet, F., Corront, B., Cony-Makhoul, P., Gastaut, J. A., Laurent, G., Molina, L., Broustet, A., Rossi, J. F., Maraninchi, D., Pris, J., Hollard, D., and Faberes, C. Autologous stem cell transplantation for acute myelogenous leukemia in adults: the BGMT experience. In: K. A. Dicke and A. Keating (eds.), Autologous Marrow and Blood Transplantation: Proceeding of the Seventh International Symposium, pp. 19-26. Arlington, Texas: The Cancer Treatment Research and Educational Institute, 1994.
3. Slavin, S., Naparstek, E., Nagler, A., Ackerstein, A., Kapelushnik, J., and Or, R. Allogeneic cell therapy for relapsed leukemia following bone marrow transplantation with donor peripheral blood lymphocytes. Exp. Hematol., 23: 1553-1562, 1995.
4. Slavin, S., Naparstek, E., Nagler, A., Ackerstein, A., Samuel, S., Kapelushnik, J., Brautbar, C., and Or, R. Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse post allogeneic bone marrow transplantation. Blood, 87: 2195-2204, 1996.
5. Kolb, H. J., Schattenberg, A., Goldman, J. M. Graft-vs-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood, 86: 2041-2050, 1995.
6. Collins, R. H., Shpilber, O., Drobyski, W. R., Porter, D. L., Giralt, S., Champlin, R., Goodman, S. A., Wolff, S. N., Hu, W., Verfaillie, C., List, A., Dalton, W., Ognoskie, N., Chetrit, A., Antin, J. H., and Neumunaitis, J., Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J. Clin. Oncol., 15: 433-444, 1997.
7. Horowitz, M., Gale, R. P., Sondel, P. M., Goldman, G. M., Kersey, J., Kolb, H. J., Rimm, A. A., Ringden, O., Rozman, C., and Speck, B. Graft-vs-leukemia reactions after bone marrow transplantation. Blood, 75: 555-562, 1990.
8. Rosti, G., Gianni, A. M., Albertazzi, L., Marangolo, M., Bjorkstrand, B. Gisselbrecht, C., Zander, A. R., Coombes, C. R., Rodenhuis, S., Efremidis, A., Conde, J. G., Ptushkin, V. V., and Philip, T. High-dose chemotherapy programs for breast cancer in Europe. In: K. A. Dicke and A. Keating (eds.), Autologous Marrow and Blood Transplantation: Proceeding of the Seventh International Symposium, pp. 207-210. Arlington, Texas: The Cancer Treatment Research and Educational Institute. 1994.
9. Antman, K., Corringham, R., and de Vries, E. G. E. Dose-intensity therapy in breast cancer. Bone Marrow Transplant., 10: 67-73, 1992.
10. Bezwoda, W. R., Seymour, L., and Dansey, R. D. High-dose chemotherapy with hematopoietic rescue as primary treatment for melastatic breast cancer: a randomized trial. J. Clin. Oncol., 13: 2483-2489, 1995.
11. Ben-Yosef, R., Or, R., Nagler, A., and Slavin, S. Graft-vs-tumor and graft-vs-leukemia in patient with concurrent breast cancer and acute myelocytic leukemia. Lancet, 348: 1242-1243, 1996.
12. Eibl, B., Schwaighofer, H., Nachbaur, D., Marth, C., Gachter, A., Knapp, R., Bock, G., Gassner, C., Schiller, L., Petersen, F., and Niederwieser, D. Evidence for a graft-versus-tumor effect in a patient treated with marrow ablative chemotherapy and allogeneic bone marrow transplantation for breast cancer. Blood, 8: 1501-1508, 1996.
13. Ueno, N. T., Rondon, G., Mirza, N. Q., Geisler, D. K., Anderlini, P., Giralt, S. A., Andersson, B. S., Claxton, D. F., Gajewski, J. L., Khouri, I. F., Korbling, M., Mehra, R. C., Przepiorka, D., Rahman, Z., Samuels, B. I., van Besien, K., Hortobagyi, G. N., and Champlin, R. E. Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer. J. Clin. Oncol., 16: 986-993, 1998.
14. Morecki, S., Moshel, Y., Gelfend, Y., Pugatsch, T., and Slavin, S. Induction of graft-vs-tumor effect in a murine model of mammary adenocarcinoma. Int. J. Cancer, 71: 59-63, 1997.
15. Dexter, D. L., Kowalski, H. M., Blazar, B. A., Fligiel, Z., Vogel, R., and Heppner, G. Heterogeneity of tumor cells from a single mouse mammary tumor. Cancer Res., 38: 3174-3181, 1978.
16. Kaplan, E., and Meier, P. Non-parametric estimation from incomplete observation. J. Am. Stat. Assoc., 53: 457-481, 1958.
17. Mantel, N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep., 50; 163-170, 1966.
18. Moscovitch, M., and Slavin, S. Anti-tumor effects of allogeneic bone marrow transplantation in (NZB x NZW) F1 hybrids with spontaneous lymphosarcoma. J. Immunol. 132: 997-1000, 1984.
19. Or, R., Ackerstein, A., Nagler, A., Kapelushnik, J., Naparstek, E., Samuel, S., Amar, A., Brautbar, C., and Slavin, S. Allogeneic cell mediated immunotherapy for breast cancer after autologous stem cell transplantation. Cytokines Cell. Mol. Ther. (Lond.), 4: 1-6, 1998.
20. Slavin, S., Weiss, L., Morecki, S., and Weisenberg, M. Eradication of murine leukemia with histocompatible marrow grafts in mice conditioned with total lymphoid irradiation (TLI). Cancer Immunol. Immunother., 11: 155-158, 1981.
21. Weiss, L., Reich, S., and Slavin, S. Use of recombinant human interleukin-2 in conjunction with bone marrow transplantation as a model for control of minimal residual disease in malignant hematological disorders. I. Treatment of murine leukemia in conjunction with allogeneic bone marrow transplantation and IL-2 activated cell-mediated immunotherapy. Cancer Invest., 10: 19-26, 1992.
22. Weiss, L., Lubin, I., Factorowich, Y., Lapidot, Z., Reich, S., Reisner, Y., and Slavin, S. Effective graft-vs-leukemia effects independent of graft-vs-host disease after T-cell depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and rIL-2. J. Immunol., 153: 2562-2567, 1994.
23. Slavin, S., Fuks, Z., Kaplan, H. S., and Strober, S. Transplantation of allogeneic bone marrow without graft-vs-host disease using total lymphoid irradiation. J. Exp. Med., 147: 963-972, 1978.
24. Johnson, B. D., Drobyski, W. R., and Truitt, R. L. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-vs-host disease. Bone Marrow Transplant., 11: 329-336, 1993.
25. Bonini, C., Ferrari, G., Verzeletti, S., Servida, P., Zappone, E., Ruggieri, L., Ponzoni, M., Rossini, S., Mavilio, F., Traversari, C., and Bordignon, C. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-vs-leukemia. Science (Washington DC), 276: 1719-1723, 1997.